최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of autoimmunity, v.85, 2017년, pp.126 - 140
Sozzani, Silvano (Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy) , Del Prete, Annalisa (Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy) , Bosisio, Daniela (Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy)
Abstract Dendritic cells (DCs) are professional antigen presenting cells displaying the unique capability to activate naïve T cells. DCs react to pathogen encounter also by the production of mediators of inflammation, including pro-inflammatory cytokines. Because of this complex role, any imba...
Annu. Rev. Immunol. Steinman 30 1 2012 10.1146/annurev-immunol-100311-102839 Decisions about dendritic cells: past, present, and future
Science Villani 356 2017 10.1126/science.aah4573 Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors
Science See 356 2017 10.1126/science.aag3009 Mapping the human DC lineage through the integration of high-dimensional techniques
Annu. Rev. Immunol. Murphy 34 93 2016 10.1146/annurev-immunol-032713-120204 Transcriptional control of dendritic cell development
Proc. Natl. Acad. Sci. U. S. A. Knight 80 6032 1983 10.1073/pnas.80.19.6032 Induction of immune responses in vivo with small numbers of veiled (dendritic) cells
Nat. Rev. Immunol. Ganguly 13 566 2013 10.1038/nri3477 The role of dendritic cells in autoimmunity
Front. Immunol. Guery 4 59 2013 10.3389/fimmu.2013.00059 Tolerogenic and activatory plasmacytoid dendritic cells in autoimmunity
Nat. Immunol. Satpathy 13 1145 2012 10.1038/ni.2467 Re(de)fining the dendritic cell lineage
Immunity Onai 38 943 2013 10.1016/j.immuni.2013.04.006 A clonogenic progenitor with prominent plasmacytoid dendritic cell developmental potential
Cell Cisse 135 37 2008 10.1016/j.cell.2008.09.016 Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development
Immunity Ghosh 33 905 2010 10.1016/j.immuni.2010.11.023 Continuous expression of the transcription factor e2-2 maintains the cell fate of mature plasmacytoid dendritic cells
Blood Schlitzer 117 6562 2011 10.1182/blood-2010-12-326678 Identification of CCR9- murine plasmacytoid DC precursors with plasticity to differentiate into conventional DCs
Blood Schlitzer 119 6063 2012 10.1182/blood-2012-03-418400 Tissue-specific differentiation of a circulating CCR9- pDC-like common dendritic cell precursor
Nat. Immunol. Hacker 4 380 2003 10.1038/ni903 Transcriptional profiling identifies Id2 function in dendritic cell development
J. Exp. Med. Spits 192 1775 2000 10.1084/jem.192.12.1775 Id2 and Id3 inhibit development of CD34(+) stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2
Blood Li 120 4363 2012 10.1182/blood-2012-07-441311 The signal transducers STAT5 and STAT3 control expression of Id2 and E2-2 during dendritic cell development
Nat. Rev. Immunol. Swiecki 15 471 2015 10.1038/nri3865 The multifaceted biology of plasmacytoid dendritic cells
Blood Marafioti 111 3778 2008 10.1182/blood-2007-10-117531 Novel markers of normal and neoplastic human plasmacytoid dendritic cells
Nat. Med. Cella 5 919 1999 10.1038/11360 Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon
Science Siegal 284 1835 1999 10.1126/science.284.5421.1835 The nature of the principal type 1 interferon-producing cells in human blood
Blood Ito 107 2423 2006 10.1182/blood-2005-07-2709 Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells
Immunol. Rev. Pestka 202 8 2004 10.1111/j.0105-2896.2004.00204.x Interferons, interferon-like cytokines, and their receptors
Immunity van Boxel-Dezaire 25 361 2006 10.1016/j.immuni.2006.08.014 Complex modulation of cell type-specific signaling in response to type I interferons
Curr. Top. Microbiol. Immunol. Uze 316 71 2007 The receptor of the type I interferon family
Curr. Pharm. Des. Deonarain 8 2131 2002 10.2174/1381612023393288 Interferon-alpha/beta-receptor interactions: a complex story unfolding
J. Interferon Res. Overall 12 281 1992 10.1089/jir.1992.12.281 Different interactions of interferon-alpha subtypes at the surface of epithelial and lymphoid cells
Proc. R. Soc. Lond. Ser. B, Biol. Sci. Isaacs 147 258 1957 Virus interference. I. The interferon
Biochimie Fitzgerald-Bocarsly 89 843 2007 10.1016/j.biochi.2007.04.018 The role of type I interferon production by dendritic cells in host defense
Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. Hervas-Stubbs 17 2619 2011 10.1158/1078-0432.CCR-10-1114 Direct effects of type I interferons on cells of the immune system
Cytokine & Growth Factor Rev. Ferrantini 19 93 2008 10.1016/j.cytogfr.2007.10.003 Dendritic cells and cytokines in immune rejection of cancer
J. Immunol. Ito 166 2961 2001 10.4049/jimmunol.166.5.2961 Differential regulation of human blood dendritic cell subsets by IFNs
J. Immunol. Luft 161 1947 1998 10.4049/jimmunol.161.4.1947 Type I IFNs enhance the terminal differentiation of dendritic cells
Eur. J. Immunol. Lapenta 36 2046 2006 10.1002/eji.200535579 IFN-alpha-conditioned dendritic cells are highly efficient in inducing cross-priming CD8(+) T cells against exogenous viral antigens
Autoimmunity Rizza 43 204 2010 10.3109/08916930903510880 Recent advances on the immunomodulatory effects of IFN-alpha: implications for cancer immunotherapy and autoimmunity
Nat. Immunol. Andoniou 6 1011 2005 10.1038/ni1244 Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity
Blood Rothenfusser 103 2162 2004 10.1182/blood-2003-04-1091 CpG-A and CpG-B oligonucleotides differentially enhance human peptide-specific primary and memory CD8+ T-cell responses in vitro
J. Exp. Med. Brinkmann 178 1655 1993 10.1084/jem.178.5.1655 Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells
Immunity Le Bon 14 461 2001 10.1016/S1074-7613(01)00126-1 Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo
Immunol. Rev. Bogdan 202 33 2004 10.1111/j.0105-2896.2004.00207.x The role of type I interferons in non-viral infections
Lupus Bengtsson 9 664 2000 10.1191/096120300674499064 Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies
J. Immunol. Dikopoulos 174 99 2005 10.4049/jimmunol.174.1.99 Type I IFN negatively regulates CD8+ T cell responses through IL-10-producing CD4+ T regulatory 1 cells
J. Immunol. Howes 197 2838 2016 10.4049/jimmunol.1501923 Differential production of type I IFN determines the reciprocal levels of IL-10 and proinflammatory cytokines produced by C57BL/6 and BALB/c macrophages
Transl. Res. J. Lab. Clin. Med. Crow 165 296 2015 Targeting of type I interferon in systemic autoimmune diseases
Cytokine & Growth Factor Rev. Gresser 13 111 2002 10.1016/S1359-6101(01)00035-1 Endogenous type I interferons as a defense against tumors
Eur. J. Immunol. Jarrossay 31 3388 2001 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells
J. Exp. Med. Kadowaki 194 863 2001 10.1084/jem.194.6.863 Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens
J. Immunol. Hornung 168 4531 2002 10.4049/jimmunol.168.9.4531 Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides
Nat. Immunol. Kawai 11 373 2010 10.1038/ni.1863 The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
Science Diebold 303 1529 2004 10.1126/science.1093616 e Sousa, Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Science Heil 303 1526 2004 10.1126/science.1093620 Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
Proc. Natl. Acad. Sci. U. S. A. Lund 101 5598 2004 10.1073/pnas.0400937101 Recognition of single-stranded RNA viruses by Toll-like receptor 7
Nature Hemmi 408 740 2000 10.1038/35047123 A Toll-like receptor recognizes bacterial DNA
Immunity Haas 28 315 2008 10.1016/j.immuni.2008.01.013 The DNA sugar backbone 2' deoxyribose determines toll-like receptor 9 activation
Nat. Immunol. Barton 7 49 2006 10.1038/ni1280 Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA
Immunity Blasius 32 305 2010 10.1016/j.immuni.2010.03.012 Intracellular toll-like receptors
Biochimie Haller 89 812 2007 10.1016/j.biochi.2007.04.015 Interferon-induced Mx proteins in antiviral host defense
Nature Honda 434 1035 2005 10.1038/nature03547 Spatiotemporal regulation of MyD88-IRF-7 signalling for robust type-I interferon induction
J. Exp. Med. Guiducci 203 1999 2006 10.1084/jem.20060401 Properties regulating the nature of the plasmacytoid dendritic cell response to toll-like receptor 9 activation
J. Immunol. Kumagai 182 3960 2009 10.4049/jimmunol.0804315 Cutting edge: TLR-dependent viral recognition along with type I IFN positive feedback signaling masks the requirement of viral replication for IFN-{alpha} production in plasmacytoid dendritic cells
Annu. Rev. Immunol. Reizis 29 163 2011 10.1146/annurev-immunol-031210-101345 Plasmacytoid dendritic cells: recent progress and open questions
J. Mol. Med. Kwidzinski 85 1351 2007 10.1007/s00109-007-0229-7 IDO expression in the brain: a double-edged sword
J. Exp. Med. Ito 204 105 2007 10.1084/jem.20061660 Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand
Immunity Durai 45 719 2016 10.1016/j.immuni.2016.10.010 Functions of murine dendritic cells
Autoimmun. Rev. Jimenez-Dalmaroni 15 1 2016 10.1016/j.autrev.2015.08.009 The critical role of toll-like receptors-From microbial recognition to autoimmunity: a comprehensive review
Science Fogg 311 83 2006 10.1126/science.1117729 A clonogenic bone marrow progenitor specific for macrophages and dendritic cells
Annu. Rev. Immunol. Merad 31 563 2013 10.1146/annurev-immunol-020711-074950 The dendritic cell lineage: ontogeny and function of dendritic cells and their subsets in the steady state and the inflamed setting
Mucosal Immunol. Sichien 10 831 2017 10.1038/mi.2017.8 Development of conventional dendritic cells: from common bone marrow progenitors to multiple subsets in peripheral tissues
Nat. Rev. Immunol. Guilliams 14 571 2014 10.1038/nri3712 Dendritic cells, monocytes and macrophages: a unified nomenclature based on ontogeny
Immunity Guilliams 45 669 2016 10.1016/j.immuni.2016.08.015 Unsupervised high-dimensional analysis aligns dendritic cells across tissues and species
Science Hildner 322 1097 2008 10.1126/science.1164206 Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity
Nat. Immunol. Grajales-Reyes 16 708 2015 10.1038/ni.3197 Batf3 maintains autoactivation of Irf8 for commitment of a CD8alpha(+) conventional DC clonogenic progenitor
Immunity Sichien 45 626 2016 10.1016/j.immuni.2016.08.013 IRF8 transcription factor controls survival and function of terminally differentiated conventional and plasmacytoid dendritic cells, respectively
J. Immunol. Bajana 189 3368 2012 10.4049/jimmunol.1102613 IRF4 promotes cutaneous dendritic cell migration to lymph nodes during homeostasis and inflammation
Immunity Persson 38 958 2013 10.1016/j.immuni.2013.03.009 IRF4 transcription-factor-dependent CD103(+)CD11b(+) dendritic cells drive mucosal T helper 17 cell differentiation
Immunity Schlitzer 38 970 2013 10.1016/j.immuni.2013.04.011 IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses
Adv. Immunol. Haniffa 120 1 2013 10.1016/B978-0-12-417028-5.00001-6 Ontogeny and functional specialization of dendritic cells in human and mouse
J. Exp. Med. Jongbloed 207 1247 2010 10.1084/jem.20092140 Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens
Blood Nizzoli 122 932 2013 10.1182/blood-2013-04-495424 Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses
J. Exp. Med. Hammad 207 2097 2010 10.1084/jem.20101563 Inflammatory dendritic cells-not basophils-are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen
J. Immunol. Campbell 186 5468 2011 10.4049/jimmunol.1002923 Differentiation of inflammatory dendritic cells is mediated by NF-kappaB1-dependent GM-CSF production in CD4 T cells
Trends Immunol. Segura 34 440 2013 10.1016/j.it.2013.06.001 Inflammatory dendritic cells in mice and humans
Immunity Segura 38 336 2013 10.1016/j.immuni.2012.10.018 Human inflammatory dendritic cells induce Th17 cell differentiation
Immunity Mashayekhi 35 249 2011 10.1016/j.immuni.2011.08.008 CD8alpha(+) dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites
Nat. Immunol. Satpathy 14 937 2013 10.1038/ni.2679 Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens
Curr. Opin. Immunol. Briseno 29 69 2014 10.1016/j.coi.2014.04.006 Complementary diversification of dendritic cells and innate lymphoid cells
Immunity Tussiwand 42 916 2015 10.1016/j.immuni.2015.04.017 Klf4 expression in conventional dendritic cells is required for T helper 2 cell responses
Immunity Swiecki 33 955 2010 10.1016/j.immuni.2010.11.020 Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual
Immunity Takagi 35 958 2011 10.1016/j.immuni.2011.10.014 Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo
Proc. Natl. Acad. Sci. U. S. A. Cervantes-Barragan 109 3012 2012 10.1073/pnas.1117359109 Plasmacytoid dendritic cells control T-cell response to chronic viral infection
J. Immunol. Swiecki 192 4409 2014 10.4049/jimmunol.1303135 Cell depletion in mice that express diphtheria toxin receptor under the control of SiglecH encompasses more than plasmacytoid dendritic cells
Proc. Natl. Acad. Sci. U. S. A. Bar-On 107 14745 2010 10.1073/pnas.1001562107 CX3CR1+ CD8alpha+ dendritic cells are a steady-state population related to plasmacytoid dendritic cells
Immunity Jung 17 211 2002 10.1016/S1074-7613(02)00365-5 D.R. Littman and R.A. Lang, in vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens
J. Exp. Med. Postigo 174 1313 1991 10.1084/jem.174.6.1313 Regulated expression and function of CD11c/CD18 integrin on human B lymphocytes. Relation between attachment to fibrinogen and triggering of proliferation through CD11c/CD18
J. Exp. Med. Guilliams 210 1977 2013 10.1084/jem.20131199 Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF
Biochem. Pharmacol. You 86 836 2013 10.1016/j.bcp.2013.07.006 Role of hepatic resident and infiltrating macrophages in liver repair after acute injury
J. Exp. Med. Meredith 209 1153 2012 10.1084/jem.20112675 Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage
J. Immunol. Methods Loschko 434 32 2016 10.1016/j.jim.2016.04.004 Inducible targeting of cDCs and their subsets in vivo
Trends Immunol. Sozzani 31 270 2010 10.1016/j.it.2010.05.004 Trafficking properties of plasmacytoid dendritic cells in health and disease
Am. J. Pathol. Farkas 159 237 2001 10.1016/S0002-9440(10)61689-6 Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions
J. Immunol. Lande 173 2815 2004 10.4049/jimmunol.173.4.2815 Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis
J. Exp. Med. Nestle 202 135 2005 10.1084/jem.20050500 Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production
J. Immunol. Penna 167 1862 2001 10.4049/jimmunol.167.4.1862 Cutting edge: selective usage of chemokine receptors by plasmacytoid dendritic cells
J. Immunol. Krug 169 6079 2002 10.4049/jimmunol.169.11.6079 IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation
J. Exp. Med. Vanbervliet 198 823 2003 10.1084/jem.20020437 The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12
J. Immunol. Kohrgruber 173 6592 2004 10.4049/jimmunol.173.11.6592 Plasmacytoid dendritic cell recruitment by immobilized CXCR3 ligands
J. General Virol. Cicinnati 89 1243 2008 10.1099/vir.0.83517-0 Altered chemotactic response of myeloid and plasmacytoid dendritic cells from patients with chronic hepatitis C: role of alpha interferon
Transplantation Cicinnati 88 504 2009 10.1097/TP.0b013e3181b0e608 Mycophenolic acid impedes the antigen presenting and lymph node homing capacities of human blood myeloid dendritic cells
Blood Schnurr 103 1391 2004 10.1182/blood-2003-06-1959 Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells
J. Immunol. Devosse 182 4974 2009 10.4049/jimmunol.0803128 Formyl peptide receptor-like 2 is expressed and functional in plasmacytoid dendritic cells, tissue-specific macrophage subpopulations, and eosinophils
J. Investig. Dermatol. Gutzmer 126 2422 2006 10.1038/sj.jid.5700416 Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a
Blood Kaser 103 648 2004 10.1182/blood-2002-07-2322 Interleukin-18 attracts plasmacytoid dendritic cells (DC2s) and promotes Th1 induction by DC2s through IL-18 receptor expression
J. Exp. Med. Vermi 201 509 2005 10.1084/jem.20041310 Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin
J. Exp. Med. Zabel 205 2207 2008 10.1084/jem.20080300 Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis
J. Exp. Med. Albanesi 206 249 2009 10.1084/jem.20080129 Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment
Blood Parolini 109 3625 2007 10.1182/blood-2006-08-038844 The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues
PloS One Graham 9 e112925 2014 10.1371/journal.pone.0112925 A novel CMKLR1 small molecule antagonist suppresses CNS autoimmune inflammatory disease
J. Autoimmun. Duraes 67 8 2016 10.1016/j.jaut.2015.08.014 pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation
Nat. Rev. Immunol. Worbs 17 30 2017 10.1038/nri.2016.116 Dendritic cell migration in health and disease
Hum. Immunol. Gill 63 1172 2002 10.1016/S0198-8859(02)00756-5 Blood dendritic cells and DC-poietins in systemic lupus erythematosus
Clin. Exp. Immunol. Migita 142 84 2005 10.1111/j.1365-2249.2005.02897.x Reduced blood BDCA-2+ (lymphoid) and CD11c+ (myeloid) dendritic cells in systemic lupus erythematosus
Lupus Jin 17 654 2008 10.1177/0961203308089410 Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression
Arthritis Res. Ther. Jongbloed 8 R15 2006 10.1186/ar1864 Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis
J. Exp. Med. Power 186 825 1997 10.1084/jem.186.6.825 Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3alpha from lung dendritic cells
J. Pathol. Page 204 28 2004 10.1002/path.1607 Paired synovium and lymph nodes from rheumatoid arthritis patients differ in dendritic cell and chemokine expression
Arthritis Rheum. Page 50 199 2004 10.1002/art.11428 Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: interaction with chemokines and Th1 cytokine-producing cells
J. Immunol. Page 168 5333 2002 10.4049/jimmunol.168.10.5333 Anatomic localization of immature and mature dendritic cells in an ectopic lymphoid organ: correlation with selective chemokine expression in rheumatoid synovium
Am. J. Pathol. Noort 185 1935 2015 10.1016/j.ajpath.2015.03.012 Tertiary lymphoid structures in rheumatoid arthritis: NF-kappaB-Inducing kinase-positive endothelial cells as central players
J. Immunol. Rodriguez-Pla 192 5586 2014 10.4049/jimmunol.1301319 IFN priming is necessary but not sufficient to turn on a migratory dendritic cell program in lupus monocytes
Nat. Med. Clatworthy 20 1458 2014 10.1038/nm.3709 Immune complexes stimulate CCR7-dependent dendritic cell migration to lymph nodes
Cytokine & Growth Factor Rev. Bondue 22 331 2011 10.1016/j.cytogfr.2011.11.004 Chemerin and its receptors in leukocyte trafficking, inflammation and metabolism
Arthritis Res. Ther. Kaneko 13 R158 2011 10.1186/ar3475 Chemerin activates fibroblast-like synoviocytes in patients with rheumatoid arthritis
Exp. Mol. Pathol. Eisinger 92 90 2012 10.1016/j.yexmp.2011.10.006 Chemerin induces CCL2 and TLR4 in synovial fibroblasts of patients with rheumatoid arthritis and osteoarthritis
Kidney Int. De Palma 79 1228 2011 10.1038/ki.2011.32 The possible role of ChemR23/Chemerin axis in the recruitment of dendritic cells in lupus nephritis
Autoimmunity Sozzani 43 196 2010 10.3109/08916930903510872 Type I interferons in systemic autoimmunity
Nat. Rev. Immunol. Gilliet 8 594 2008 10.1038/nri2358 Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases
Autoimmunity Pisetsky 40 281 2007 10.1080/08916930701358826 The origin of extracellular DNA during the clearance of dead and dying cells
Front. Immunol. Yang 7 302 2016 10.3389/fimmu.2016.00302 New insights into neutrophil extracellular traps: mechanisms of formation and role in inflammation
Curr. Opin. Rheumatol. Smith 27 448 2015 10.1097/BOR.0000000000000197 The role of neutrophils in the pathogenesis of systemic lupus erythematosus
Nature Lande 449 564 2007 10.1038/nature06116 Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Sci. Transl. Med. Lande 3 73ra19 2011 10.1126/scitranslmed.3001180 Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus
Eur. J. Immunol. Lande 45 203 2015 10.1002/eji.201344277 Cationic antimicrobial peptides in psoriatic skin cooperate to break innate tolerance to self-DNA
J. Biol. Chem. Sandgren 279 17951 2004 10.1074/jbc.M311440200 The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis
Nat. Immunol. Tian 8 487 2007 10.1038/ni1457 Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE
Nat. Med. Diana 19 65 2013 10.1038/nm.3042 Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes
Arthritis Rheum. Lovgren 50 1861 2004 10.1002/art.20254 Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG
J. Exp. Med. Barrat 202 1131 2005 10.1084/jem.20050914 Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus
J. Clin. Investig. Means 115 407 2005 10.1172/JCI23025 Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9
Immunity Henault 37 986 2012 10.1016/j.immuni.2012.09.014 Noncanonical autophagy is required for type I interferon secretion in response to DNA-immune complexes
Autoimmun. Rev. Chan 11 890 2012 10.1016/j.autrev.2012.03.004 Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus
Arthritis Rheum. Bave 52 1185 2005 10.1002/art.20998 Activation of the type I interferon system in primary Sjogren's syndrome: a possible etiopathogenic mechanism
Arthritis Rheum. Eloranta 56 3112 2007 10.1002/art.22860 A possible mechanism for endogenous activation of the type I interferon system in myositis patients with anti-Jo-1 or anti-Ro 52/anti-Ro 60 autoantibodies
Ann. Rheum. Dis. Eloranta 69 1396 2010 10.1136/ard.2009.121400 Type I interferon system activation and association with disease manifestations in systemic sclerosis
J. Exp. Med. Ganguly 206 1983 2009 10.1084/jem.20090480 Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8
J. Exp. Med. Vollmer 202 1575 2005 10.1084/jem.20051696 Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8
Semin. Immunol. Christensen 19 11 2007 10.1016/j.smim.2006.12.005 Regulation of lupus-related autoantibody production and clinical disease by Toll-like receptors
Front. Genet. Turchinovich 4 119 2013 10.3389/fgene.2013.00119 Circulating miRNAs: cell-cell communication function?
Proc. Natl. Acad. Sci. U. S. A. Fabbri 109 E2110 2012 10.1073/pnas.1209414109 MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
Nat. Neurosci. Lehmann 15 827 2012 10.1038/nn.3113 An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration
Autoimmun. Rev. Chen 15 1171 2016 10.1016/j.autrev.2016.09.003 The role of microRNAs in the pathogenesis of autoimmune diseases
Oncotarget Wang 8 5498 2017 10.18632/oncotarget.12534 Role of an imbalanced miRNAs axis in pathogenesis of psoriasis: novel perspectives based on review of the literature
Nat. Med. Kortylewski 11 1314 2005 10.1038/nm1325 Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity
Arthritis Rheum. Hartgring 63 1878 2011 10.1002/art.30336 Critical proinflammatory role of thymic stromal lymphopoietin and its receptor in experimental autoimmune arthritis
Arthritis Rheumatol. Moret 66 1176 2014 10.1002/art.38338 Thymic stromal lymphopoietin, a novel proinflammatory mediator in rheumatoid arthritis that potently activates CD1c+ myeloid dendritic cells to attract and stimulate T cells
Arthritis Rheum. van Roon 52 1700 2005 10.1002/art.21045 Increased intraarticular interleukin-7 in rheumatoid arthritis patients stimulates cell contact-dependent activation of CD4(+) T cells and macrophages
Arthritis Res. Ther. Moret 16 497 2014 10.1186/s13075-014-0497-x Synovial T cell hyporesponsiveness to myeloid dendritic cells is reversed by preventing PD-1/PD-L1 interactions
Ann. Rheum. Dis. Reynolds 75 899 2016 10.1136/annrheumdis-2014-206578 Synovial CD4+ T-cell-derived GM-CSF supports the differentiation of an inflammatory dendritic cell population in rheumatoid arthritis
Proc. Natl. Acad. Sci. U. S. A. Lee 102 15995 2005 10.1073/pnas.0508122102 The role of TNF-alpha in the pathogenesis of type 1 diabetes in the nonobese diabetic mouse: analysis of dendritic cell maturation
Immunity Kim 27 321 2007 10.1016/j.immuni.2007.06.010 Toll-like receptor 2 senses beta-cell death and contributes to the initiation of autoimmune diabetes
Proc. Natl. Acad. Sci. U. S. A. Desnues 111 1497 2014 10.1073/pnas.1314121111 TLR8 on dendritic cells and TLR9 on B cells restrain TLR7-mediated spontaneous autoimmunity in C57BL/6 mice
Immunity Teichmann 38 528 2013 10.1016/j.immuni.2012.11.017 Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus
Proc. Natl. Acad. Sci. U. S. A. Lamagna 110 E3311 2013 10.1073/pnas.1300617110 Hyperactivated MyD88 signaling in dendritic cells, through specific deletion of Lyn kinase, causes severe autoimmunity and inflammation
Arthritis Rheum. Tada 63 738 2011 10.1002/art.30183 Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice
Immunity Kool 35 82 2011 10.1016/j.immuni.2011.05.013 The ubiquitin-editing protein A20 prevents dendritic cell activation, recognition of apoptotic cells, and systemic autoimmunity
Blood Chen 109 4360 2007 10.1182/blood-2006-11-056424 Deficiency of Bim in dendritic cells contributes to overactivation of lymphocytes and autoimmunity
Proc. Natl. Acad. Sci. U. S. A. Celhar 112 E6195 2015 10.1073/pnas.1507052112 RNA sensing by conventional dendritic cells is central to the development of lupus nephritis
Ann. Rheum. Dis. Jensen 72 596 2013 10.1136/annrheumdis-2012-202024 Functional genetic polymorphisms in ILT3 are associated with decreased surface expression on dendritic cells and increased serum cytokines in lupus patients
Arthritis Rheum. Xie 63 2425 2011 10.1002/art.30420 17beta-estradiol induces CD40 expression in dendritic cells via MAPK signaling pathways in a minichromosome maintenance protein 6-dependent manner
Mol. Immunol. Csomor 44 3389 2007 10.1016/j.molimm.2007.02.014 Complement protein C1q induces maturation of human dendritic cells
Mol. Immunol. Teh 48 1128 2011 10.1016/j.molimm.2011.02.006 C1q regulation of dendritic cell development from monocytes with distinct cytokine production and T cell stimulation
Immunity Stranges 26 629 2007 10.1016/j.immuni.2007.03.016 Elimination of antigen-presenting cells and autoreactive T cells by Fas contributes to prevention of autoimmunity
J. Immunol. Chen 187 5684 2011 10.4049/jimmunol.1101834 Immune regulation through mitochondrion-dependent dendritic cell death induced by T regulatory cells
Nat. Immunol. Ramirez-Ortiz 14 917 2013 10.1038/ni.2670 The scavenger receptor SCARF1 mediates the clearance of apoptotic cells and prevents autoimmunity
Proc. Natl. Acad. Sci. U. S. A. Wohn 110 10723 2013 10.1073/pnas.1307569110 Langerin(neg) conventional dendritic cells produce IL-23 to drive psoriatic plaque formation in mice
J. Immunol. Decker 174 3326 2005 10.4049/jimmunol.174.6.3326 Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a MyD88-independent pathway: consequences on inflammation
J. Immunol. Kis-Toth 187 1222 2011 10.4049/jimmunol.1100469 Cytosolic DNA-activated human dendritic cells are potent activators of the adaptive immune response
J. Mol. Med. Eloranta 94 1103 2016 10.1007/s00109-016-1421-4 Cause and consequences of the activated type I interferon system in SLE
J. Rheumatol. Ytterberg 10 906 1983 Effects of serum from patients with system lupus erythematosus on leukocyte cytotoxicity: modulation of NK activity and ADCC
Lupus Blomberg 10 484 2001 10.1191/096120301678416042 Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus
J. Exp. Med. Bennett 197 711 2003 10.1084/jem.20021553 Interferon and granulopoiesis signatures in systemic lupus erythematosus blood
Arthritis Rheum. Hjelmervik 52 1534 2005 10.1002/art.21006 Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren's syndrome patients from healthy control subjects
Immunol. Rev. Baechler 210 120 2006 10.1111/j.0105-2896.2006.00367.x Gene expression profiling in human autoimmunity
Ann. Rheum. Dis. Higgs 70 2029 2011 10.1136/ard.2011.150326 Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway
J. Interferon Res. Schmid 14 229 1994 10.1089/jir.1994.14.229 The type I interferon system is locally activated in psoriatic lesions
PloS One Yao 3 e2737 2008 10.1371/journal.pone.0002737 Type I interferon: potential therapeutic target for psoriasis?
J. Exp. Med. Joo 209 1335 2012 10.1084/jem.20111644 Serum from patients with SLE instructs monocytes to promote IgG and IgA plasmablast differentiation
Proc. Natl. Acad. Sci. U. S. A. Li 105 12439 2008 10.1073/pnas.0806439105 Interferon-alpha initiates type 1 diabetes in nonobese diabetic mice
J. Investig. Dermatol. Wollenberg 119 1096 2002 10.1046/j.1523-1747.2002.19515.x Plasmacytoid dendritic cells: a new cutaneous dendritic cell subset with distinct role in inflammatory skin diseases
J. Exp. Med. Dzionek 194 1823 2001 10.1084/jem.194.12.1823 BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction
Diabetes Sobel 47 1867 1998 10.2337/diabetes.47.12.1867 Alpha-interferon inhibits the development of diabetes in NOD mice
Life Sci. Sobel 62 1293 1998 10.1016/S0024-3205(98)00063-0 Alpha interferon administration paradoxically inhibits the development of diabetes in BB rats
J. Interferon & Cytokine Res. Off. J. Int. Soc. Interferon Cytokine Res. Tanaka-Kataoka 19 877 1999 10.1089/107999099313398 Oral use of interferon-alpha delays the onset of insulin-dependent diabetes mellitus in nonobese diabetes mice
Exp. Biol. Med. Brod 227 981 2002 10.1177/153537020222701105 Ingested type I interferon: state of the art as treatment for autoimmunity
Arterioscler., Thromb., Vasc. Biol. Macritchie 32 2569 2012 10.1161/ATVBAHA.112.251314 Plasmacytoid dendritic cells play a key role in promoting atherosclerosis in apolipoprotein E-deficient mice
Proc. Natl. Acad. Sci. U. S. A. Baccala 110 2940 2013 10.1073/pnas.1222798110 Essential requirement for IRF8 and SLC15A4 implicates plasmacytoid dendritic cells in the pathogenesis of lupus
J. Exp. Med. Sisirak 211 1969 2014 10.1084/jem.20132522 Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus
J. Exp. Med. Rowland 211 1977 2014 10.1084/jem.20132620 Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model
Mult. Scler. Goodkin 1 321 1996 10.1177/135245859600100605 Interferon beta treatment for multiple sclerosis: persisting questions
Cytokine & Growth Factor Rev. Annibali 26 221 2015 10.1016/j.cytogfr.2014.10.010 IFN-beta and multiple sclerosis: from etiology to therapy and back
Immunity Prinz 28 675 2008 10.1016/j.immuni.2008.03.011 Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system
Immunotherapy von Glehn 4 1053 2012 10.2217/imt.12.117 Plasmacytoid dendritic cells and immunotherapy in multiple sclerosis
Eur. J. Immunol. Isaksson 39 2925 2009 10.1002/eji.200839179 Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE
J. Immunol. Bailey-Bucktrout 180 6457 2008 10.4049/jimmunol.180.10.6457 Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis
Nat. Immunol. Bailey 8 172 2007 10.1038/ni1430 CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE
J. Exp. Med. Irla 207 1891 2010 10.1084/jem.20092627 MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity
Am. J. Pathol. Lebre 172 940 2008 10.2353/ajpath.2008.070703 Rheumatoid arthritis synovium contains two subsets of CD83-DC-LAMP- dendritic cells with distinct cytokine profiles
Arthritis Rheum. Tournadre 64 533 2012 10.1002/art.33350 Immature muscle precursors are a source of interferon-beta in myositis: role of Toll-like receptor 3 activation and contribution to HLA class I up-regulation
Arthritis Res. Ther. Moret 15 R155 2013 10.1186/ar4338 Intra-articular CD1c-expressing myeloid dendritic cells from rheumatoid arthritis patients express a unique set of T cell-attracting chemokines and spontaneously induce Th1, Th17 and Th2 cell activity
Nat. Rev. Rheumatol. Takayanagi 5 667 2009 10.1038/nrrheum.2009.217 Osteoimmunology and the effects of the immune system on bone
Ann. Rheum. Dis. Hot 70 727 2011 10.1136/ard.2010.143768 Effects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes
Blood Rivollier 104 4029 2004 10.1182/blood-2004-01-0041 Immature dendritic cell transdifferentiation into osteoclasts: a novel pathway sustained by the rheumatoid arthritis microenvironment
Proc. Natl. Acad. Sci. U. S. A. Lowes 102 19057 2005 10.1073/pnas.0509736102 Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)
Nat. Med. Greter 11 328 2005 10.1038/nm1197 Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis
Proc. Natl. Acad. Sci. U. S. A. Poppensieker 109 3897 2012 10.1073/pnas.1114153109 CC chemokine receptor 4 is required for experimental autoimmune encephalomyelitis by regulating GM-CSF and IL-23 production in dendritic cells
Nat. Immunol. Codarri 12 560 2011 10.1038/ni.2027 RORgammat drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation
Nat. Immunol. El-Behi 12 568 2011 10.1038/ni.2031 The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF
Am. J. Respir. Cell Mol. Biol. Zaba 42 32 2010 10.1165/rcmb.2009-0033TR Dendritic cells in the pathogenesis of sarcoidosis
Eur. Respir. J. Lommatzsch 30 878 2007 10.1183/09031936.00036307 Airway dendritic cell phenotypes in inflammatory diseases of the human lung
J. Immunol. Shigehara 166 642 2001 10.4049/jimmunol.166.1.642 IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs
Nature Maloy 474 298 2011 10.1038/nature10208 Intestinal homeostasis and its breakdown in inflammatory bowel disease
Eur. J. Immunol. Benedetti 44 339 2014 10.1002/eji.201344184 Interleukin 17 contributes to the chronicity of inflammatory diseases such as rheumatoid arthritis
J. Rheumatol. Prevosto 39 1918 2012 10.3899/jrheum.120208 Cytokine secretion by pathogen recognition receptor-stimulated dendritic cells in rheumatoid arthritis and ankylosing spondylitis
J. Autoimmun. Gravano 45 68 2013 10.1016/j.jaut.2013.06.004 Promotion and prevention of autoimmune disease by CD8+ T cells
J. Clin. Investig. Drobits 122 575 2012 10.1172/JCI61034 Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells
J. Immunol. Chaperot 176 248 2006 10.4049/jimmunol.176.1.248 Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells
J. Immunol. Kalb 188 1583 2012 10.4049/jimmunol.1102437 TRAIL(+) human plasmacytoid dendritic cells kill tumor cells in vitro: mechanisms of imiquimod- and IFN-alpha-mediated antitumor reactivity
Immunobiology Riboldi 214 868 2009 10.1016/j.imbio.2009.06.016 Engagement of BDCA-2 blocks TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells
Br. J. Dermatol. Zahn 165 1118 2011 10.1111/j.1365-2133.2011.10479.x Interferon-alpha stimulates TRAIL expression in human keratinocytes and peripheral blood mononuclear cells: implications for the pathogenesis of cutaneous lupus erythematosus
Blood Karrich 121 3103 2013 10.1182/blood-2012-08-452995 IL-21-stimulated human plasmacytoid dendritic cells secrete granzyme B, which impairs their capacity to induce T-cell proliferation
J. Investig. Dermatol. Salvi 137 1493 2017 10.1016/j.jid.2017.03.016 IL-21 may promote granzyme B-Dependent NK/plasmacytoid dendritic cell functional interaction in cutaneous lupus erythematosus
Nat. Med. Caruso 15 1013 2009 10.1038/nm.1995 Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis
J. Br. Soc. Allergy Clin. Immunol. Bratke 40 1015 2010 Functional expression of granzyme B in human plasmacytoid dendritic cells: a role in allergic inflammation, Clinical and experimental allergy
Lancet Wahren-Herlenius 382 819 2013 10.1016/S0140-6736(13)60954-X Immunopathogenic mechanisms of systemic autoimmune disease
Lab. Investig.; a J. Tech. Methods Pathol. Boivin 89 1195 2009 10.1038/labinvest.2009.91 Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma
Acta Pharmacol. Sin. Wu 36 1395 2015 10.1038/aps.2015.91 Toll-like receptors: potential targets for lupus treatment
Nat. Rev. Rheumatol. Coutant 12 703 2016 10.1038/nrrheum.2016.147 Altered dendritic cell functions in autoimmune diseases: distinct and overlapping profiles
Diabetes Care Giannoukakis 34 2026 2011 10.2337/dc11-0472 Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients
Immunotherapy Giannoukakis 5 919 2013 10.2217/imt.13.89 Immunoregulatory dendritic cells to treat autoimmunity are ready for the clinic. Interview by Katie Lockwood
Sci. Transl. Med. Benham 7 290ra87 2015 10.1126/scitranslmed.aaa9301 Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients
Ann. Rheum. Dis. Bell 76 227 2017 10.1136/annrheumdis-2015-208456 Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis
Scand. J. Immunol. Figueroa-Vega 64 668 2006 10.1111/j.1365-3083.2006.01849.x Phenotypic analysis of IL-10-treated, monocyte-derived dendritic cells in patients with systemic lupus erythematosus
Immunology Wu 149 48 2016 10.1111/imm.12628 Rel B-modified dendritic cells possess tolerogenic phenotype and functions on lupus splenic lymphocytes in vitro
Autoimmun. Rev. Mackern-Oberti 14 127 2015 10.1016/j.autrev.2014.10.010 Role of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases
J. Immunol. Res. Lee 2016 5392623 2016 Immunomodulatory effects of 1,25-dihydroxyvitamin D3 on dendritic cells promote Induction of T Cell hyporesponsiveness to myelin-derived antigens
J. Immunol. Sozzani 155 3292 1995 10.4049/jimmunol.155.7.3292 Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines
Arthritis Rheumatol. Wang 67 2403 2015 10.1002/art.39211 PTPN22 variant R620W is associated with reduced toll-like receptor 7-induced type I interferon in systemic lupus erythematosus
※ AI-Helper는 부적절한 답변을 할 수 있습니다.